AI-based clinical trial solutions market to hit $2.4b by 2030

One key driver is the growing complexity of trial designs.

The global artificial intelligence (AI)-based clinical trial solutions market for patient matching is projected to reach $2.4b by 2030 at a compound annual growth rate of 24.8%, according to Research and Markets.

The sector’s expansion is attributed to the growing complexity of trial designs and the rising prevalence of chronic and rare diseases.

Meanwhile, supportive regulatory initiatives and developments in AI algorithms and cloud computing are further driving market growth.

“Consumer behaviour trends, such as the increasing use of wearable health devices and patient portals, are generating valuable real-time data that can be leveraged for patient matching,” the report said.